Lenire proudly sponsors the 10 th Annual LexCare Hearing Foundation Hearoes Tour. Lenire is a treatment option for 3.2m veterans living with tinnitus. The Hearoes Tour is a national movement that ...

Lenire is now Tinnitus UK's safest and most effective available tinnitus treatment option following a wholesale review of the charity's rating system. Tinnitus UK's new rating acknowledges Lenire's ...

Plenty of us experience tinnitus – an awareness of a persistent and unpleasant ringing in the ears that can make life miserable. There's a recently approved device that treats it, but it ain't cheap.

The FDA-approved Lenire device that provides bimodal stimulation with a controller, tongue tip stimulator and wireless headphones. An FDA-approved device for treating tinnitus is showing strong ...

Lenire, developed by Neuromod Devices Ltd., is a device that uses a plastic mouthpiece with stainless steel electrodes to deliver electrical stimulation to the tongue while the user hears the sound of ...

NEW YORK, Feb. 17, 2026 /PRNewswire/ -- The American Journal of Audiology has peer-reviewed and published the positive outcomes of U.S. tinnitus patients treated with Lenire, the only FDA approved ...

Lenire® is a bimodal neuromodulation device which has been proven to provide long term relief from tinnitus that lasts for at least 12-months after treatment in large scale clinical trials. [1],[3] ...

Nearly half of all Canadian adults have experienced tinnitus in their lifetime and a new at-home tinnitus treatment device offers chronic sufferers hope. Lenire will be exclusively available through ...

CHICAGO, April 7, 2025 /PRNewswire/ — Lenire, the first and only FDA Approved tinnitus treatment device of its kind, is proud to sponsor the 10th Annual LexCare Hearing Foundation Hearoes Tour to ...

DUBLIN, April 29, 2024 /PRNewswire/ -- Lenire, the first and only FDA approved bimodal neuromodulation device for the treatment of tinnitus, has been included in the seminal "Textbook of Tinnitus," ...